Use of the antifibrinolytic medication ‘narrowly exceeded’ noninferiority in VTE risk compared with placebo in noncardiac ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Transient loss of vision is associated with an increased risk for cardiovascular events within 14 days of diagnosis, and ...

"Patients with cancer-associated thrombosis are both at risk of recurrent venous thromboembolism and bleeding during extended ...

Winter's chill significantly escalates the risk of serious heart conditions, including heart attacks, strokes, and blood ...

When I first rotated onto the acute care unit (ACU) at the Countess of Chester Hospital, it didn’t take long to realise that ...

While generally safe, multivitamins can change how other medications work, affect how much medication gets absorbed into your bloodstream, or create unwanted nutrient buildup.

A new study published in the Journal of American Medical Association showed that over the course of a year, respiratory ...

Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing ...

Giredestrant significantly improved IDFS over SOC endocrine therapy, reducing the risk of invasive disease recurrence or ...

Research suggests a surprising link between blood type and stroke risk, with people carrying one specific group A blood type ...

Giredestrant significantly improved IDFS in ER-positive, HER2-negative early breast cancer, reducing recurrence or death risk by 30% compared to SOC endocrine therapy. Subgroup analyses showed ...